Keywords:
Malaria; antimalarials; artemisinins; epidemiology; pharmacology; parasitology; genetics
Abstract:
Current malaria elimination targets must withstand a colossal challenge-resistance to the current gold standard antimalarial drug, namely artemisinin derivatives. If artemisinin resistance significantly expands to Africa or India, cases and malaria-related deaths are set to increase substantially.